溴苄铵抗纤颤作用的动力学：与心肌药物浓度的相关性 - Suppr

Suppr

超能文献

Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.

作者信息

Anderson J L, Patterson E, Conlon M, Pasyk S, Pitt B, Lucchesi B R

出版信息

Am J Cardiol. 1980 Oct;46(4):583-92. doi: 10.1016/0002-9149(80)90507-x.

DOI:10.1016/0002-9149(80)90507-x

PMID:7416018

Abstract

摘要

相似文献

Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.

Am J Cardiol. 1980 Oct;46(4):583-92. doi: 10.1016/0002-9149(80)90507-x.

Bretylium tosylate: profile of the only available class III antiarrhythmic agent.

Clin Ther. 1985;7(2):205-24.

The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.

J Pharmacol Exp Ther. 1975 Jan;192(1):120-8.

Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.

Am J Cardiol. 1984 Jul 30;54(2):14A-19A. doi: 10.1016/0002-9149(84)90812-9.

Sensitive gas chromatographic assay for the quantitation of bretylium in plasma, urine and myocardial tissue.

J Chromatogr. 1980 Jan 11;181(1):33-9. doi: 10.1016/s0378-4347(00)81266-9.

Antifibrillatory action of bretylium: role of the sympathetic nervous system.

Pharmacology. 1987;34(1):37-47. doi: 10.1159/000138246.

The anti-arrhythmic action of bretylium in normal reserpine-pretreated and chronically denervated dog hearts.

Arch Int Pharmacodyn Ther. 1971 Mar;190(1):91-102.

In vitro preparation of infarcted myocardium.

Environ Health Perspect. 1978 Oct;26:233-42. doi: 10.1289/ehp.7826233.

The effect of bretylium tosylate on ventricular function.

Am J Med Sci. 1973 Apr;265(4):287-95. doi: 10.1097/00000441-197304000-00004.

[Actions of anti-arrhythmic agents on physiology of myocardial cell membrane].

Nihon Rinsho. 1974 Sep;32(9):2829-34.

引用本文的文献

What is New in Pharmacologic Therapy for Cardiac Resuscitation?

Cardiol Res. 2020 Jun;11(3):141-144. doi: 10.14740/cr1058. Epub 2020 May 3.

Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.

Br J Pharmacol. 2007 Jun;151(3):356-66. doi: 10.1038/sj.bjp.0707234. Epub 2007 Apr 10.

Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.

Postgrad Med J. 1993 Dec;69(818):903-11. doi: 10.1136/pgmj.69.818.903.

New antiarrhythmic drugs: their place in therapy.

Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002.

Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Clin Pharmacokinet. 1984 Jul-Aug;9(4):273-308. doi: 10.2165/00003088-198409040-00001.

Clinical pharmacokinetics of bretylium.

Clin Pharmacokinet. 1985 May-Jun;10(3):248-56. doi: 10.2165/00003088-198510030-00004.

Myocardial uptake of drugs and clinical effects.

Clin Pharmacokinet. 1986 Sep-Oct;11(5):354-71. doi: 10.2165/00003088-198611050-00002.

Potassium channel blockade: A mechanism for suppressing ventricular fibrillation.

Proc Natl Acad Sci U S A. 1986 Apr;83(7):2223-7. doi: 10.1073/pnas.83.7.2223.

[Acute myocardial uptake of lidocaine, mexiletine and amiodarone].

Klin Wochenschr. 1990 Jul 5;68(13):673-7. doi: 10.1007/BF01667015.

Pharmacological analysis of established ventricular fibrillation.

Br J Pharmacol. 1990 Jul;100(3):530-4. doi: 10.1111/j.1476-5381.1990.tb15841.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验